Experimental and applied immunotherapy
Publié par : Humana Press (New York) Détails physiques : xvii, 442 pages illustrations (chiefly color) 25 cm. ISBN :9781607619796 (alk. paper); 1607619792 (alk. paper); 9781607619802 (eISBN); 1607619806 (eISBN).Type de document | Site actuel | Cote | Statut | Date de retour prévue | Code à barres | Réservations |
---|---|---|---|---|---|---|
Livre | La bibliothèque des Sciences Médicales et Pharmaceutiques | 616.079 MED (Parcourir l'étagère) | Disponible | 0000000023700 |
Includes bibliographical references and index.
T cell therapy: state-of-the-art -- Extending the use of adoptive T cell immunotherapy for infections and cancer -- Non-T cell therapeutic approaches -- B lymphocytes in cancer immunology -- Monoclonal antibody therapy for cancer -- Natural killer cells for cancer immunotherapy -- Dendritic cell-based cancer vaccines: practical considerations -- Mesenchymal stromal cells: an emerging cell-based pharmaceutical -- T cell therapeutic approaches -- Tumor-specific mutations as targets for cancer immunotherapy -- Counteracting subversion of MHC class II antigen presentation by tumors -- Mechanisms and implications of immunodominance in CD8⁺ T-cell responses -- T regulatory cells and cancer immunotherapy -- Negative regulators in cancer immunology and immunotherapy -- Genetically engineered antigen specificity in T cells for adoptive immunotherapy -- Non-cellular aspects of cancer immunotherapy -- Cytokine immunotherapy -- Transcriptional modulation using histone deacetylase inhibitors for cancer immunotherapy -- Combining cancer vaccines with conventional therapies -- Combining oncolytic viruses with cancer immunotherapy -- Radiation therapy and cancer treatment: from the basics to combination therapies that ignite immunity -- Assessing immunotherapy through cellular and molecular imaging -- Transplantation -- Allogeneic and autologous transplantation therapy of cancer: converging themes.
Il n'y a pas de commentaire pour ce document.